An Ensemble Prognostic Model for Colorectal Cancer
Open Access
- 2 May 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (5) , e63494
Abstract
Colorectal cancer can be grouped into Dukes A, B, C, and D stages based on its developments. Generally speaking, more advanced patients have poorer prognosis. To integrate progression stage prediction systems with recurrence prediction systems, we proposed an ensemble prognostic model for colorectal cancer. In this model, each patient was assigned a most possible stage and a most possible recurrence status. If a patient was predicted to be recurrence patient in advanced stage, he would be classified into high risk group. The ensemble model considered both progression stages and recurrence status. High risk patients and low risk patients predicted by the ensemble model had a significant different disease free survival (log-rank test p-value, 0.0016) and disease specific survival (log-rank test p-value, 0.0041). The ensemble model can better distinguish the high risk and low risk patients than the stage prediction model and the recurrence prediction model alone. This method could be applied to the studies of other diseases and it could significantly improve the prediction performance by ensembling heterogeneous informationKeywords
This publication has 51 references indexed in Scilit:
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Epigenetic Alteration of PRKCDBP in Colorectal Cancers and Its Implication in Tumor Cell Resistance to TNFα-Induced ApoptosisClinical Cancer Research, 2011
- S100A8/A9 Activate Key Genes and Pathways in Colon Tumor ProgressionMolecular Cancer Research, 2011
- The STRING database in 2011: functional interaction networks of proteins, globally integrated and scoredNucleic Acids Research, 2010
- SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignanciesMolecular Cancer, 2010
- Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal CancerClinical Cancer Research, 2009
- Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant β-Catenin Activation in Colon CancerClinical Cancer Research, 2009
- Akt and 14-3-3 Control a PACS-2 Homeostatic Switch that Integrates Membrane Traffic with TRAIL-Induced ApoptosisMolecular Cell, 2009
- Towards a proteome-scale map of the human protein–protein interaction networkNature, 2005
- Molecular Staging for Survival Prediction of Colorectal Cancer PatientsJournal of Clinical Oncology, 2005